Central African Republic vs Vanuatu: The number of people with susceptibility test result for rifampicin
Central African Republic
9.75
in 2021
Vanuatu
0
in 2021
Central African Republic rank
139th
Vanuatu rank
142nd
The number of people with susceptibility test result for rifampicin over time
- Central African Republic
- Vanuatu
How they compare
Central African Republic currently reports 9.75 against 0 in Vanuatu, a difference of 9.75.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Vanuatu ahead.
Central African Republic ranks 139th and Vanuatu ranks 142nd of 146 countries.
Vanuatu has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Central African Republic | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.64 | 99.29 | 97.65 | Vanuatu |
| 2020s | 10.12 | 46.74 | 36.62 | Vanuatu |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Central African Republic or Vanuatu?
- Central African Republic, at 9.75 against 0 in Vanuatu as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Central African Republic and Vanuatu?
- 9.75, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and Vanuatu?
- 5 years are reported by both, from 2017 to 2021.
- How do Central African Republic and Vanuatu rank globally for the number of people with susceptibility test result for rifampicin?
- Central African Republic ranks 139th and Vanuatu ranks 142nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.